1. Home
  2. RNXT vs KSCP Comparison

RNXT vs KSCP Comparison

Compare RNXT & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • KSCP
  • Stock Information
  • Founded
  • RNXT 2012
  • KSCP 2013
  • Country
  • RNXT United States
  • KSCP United States
  • Employees
  • RNXT N/A
  • KSCP N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • KSCP Telecommunications Equipment
  • Sector
  • RNXT Health Care
  • KSCP Telecommunications
  • Exchange
  • RNXT Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • RNXT 44.6M
  • KSCP 35.9M
  • IPO Year
  • RNXT 2021
  • KSCP 2022
  • Fundamental
  • Price
  • RNXT $1.32
  • KSCP $7.68
  • Analyst Decision
  • RNXT Strong Buy
  • KSCP Strong Buy
  • Analyst Count
  • RNXT 2
  • KSCP 3
  • Target Price
  • RNXT $7.25
  • KSCP $15.67
  • AVG Volume (30 Days)
  • RNXT 150.2K
  • KSCP 451.0K
  • Earning Date
  • RNXT 08-14-2025
  • KSCP 08-13-2025
  • Dividend Yield
  • RNXT N/A
  • KSCP N/A
  • EPS Growth
  • RNXT N/A
  • KSCP N/A
  • EPS
  • RNXT N/A
  • KSCP N/A
  • Revenue
  • RNXT $240,000.00
  • KSCP $11,468,000.00
  • Revenue This Year
  • RNXT $3,104.65
  • KSCP $16.17
  • Revenue Next Year
  • RNXT $301.89
  • KSCP $39.02
  • P/E Ratio
  • RNXT N/A
  • KSCP N/A
  • Revenue Growth
  • RNXT N/A
  • KSCP N/A
  • 52 Week Low
  • RNXT $0.75
  • KSCP $2.45
  • 52 Week High
  • RNXT $1.69
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 50.28
  • KSCP 74.90
  • Support Level
  • RNXT $1.28
  • KSCP $6.88
  • Resistance Level
  • RNXT $1.40
  • KSCP $8.31
  • Average True Range (ATR)
  • RNXT 0.07
  • KSCP 0.56
  • MACD
  • RNXT -0.01
  • KSCP 0.31
  • Stochastic Oscillator
  • RNXT 40.74
  • KSCP 96.18

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: